Byeong Jo Jeon

Byeong Jo Jeon

Auto-generated profile, based on publicly available information

Byeong Jo Jeon

Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2019 in International Neurourology Journal
Verified
Journal Article
Open access
PDF file
BJByeong Jo Jeon
Byeong Jo Jeon
HCHong Chung
Hong Chung
JBJae Hyun Bae
Jae Hyun Bae
HJHan Jung
Han Jung
JLJeong Gu Lee
Jeong Gu Lee
HCHoon Choi
Hoon Choi
There are no established statistical data available for the comparison of different surgical methods adopted for the resection of benign prostatic hyperplasia (BPH). This study investigates the present status related to BPH surgery in Korea for the past 8 years. National-level data from the National Health Insurance Service and National Statistical Office were analyzed in this study. From 2010 to 2017, the trends of surgeries for BPH were reviewed according to the procedure code including transurethral resection of the prostate (TURP), holmium laser enucleation of the prostate (HoLEP), or high-power potassium titanyl phosphate (KTP), and this trend also analyzed by age, geographic distribution, and hospital type. Over the past 8 years, there was not much change in the total number of BPH-related surgeries (range, 10,393- 11,072). Although there was not much alteration in the number of conventional TURP (from 6,801 in 2010 to 6,645 in 2017), the number of HoLEP has dramatically increased (from 278 in 2010 to 3,805 in 2017). The number of HoLEP surgeries after 2011 exceeded the number of surgeries using KTP, and the gap is anticipated to rise. The number of surgeries by age group was most common in the 70s and the total number of surgeries is decreasing in all age groups; for HoLEP, the trend is steadily increasing over the age of 60 years. Most of the BPH surgeries were performed in metropolitan areas, such as Seoul, Gyeonggido, and Busan, and in larger hospitals compared to smaller hospital settings. Through the data of the National Health Insurance Service, we could apprehend the present status of BPH-related surgery in Korea. Then, we could know about the trend according to several factors and we think these results will be valuable as academic references as well.

1 January 2024 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
BJByeong Jo Jeon
Byeong Jo Jeon
YKYou Jin Ko
You Jin Ko
JCJin Joo Cha
Jin Joo Cha
CKCherry Kim
Cherry Kim
Min Young SeoMin Young Seo
Min Young Seo
BTBum Sik Tae
Bum Sik Tae
Jeon BJ, et al. J Korean Med Sci. 2024 Aug;39:e259. https://doi.org/10.3346/jkms.2024.39.e259

1 January 2020 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
BJByeong Jo Jeon
Byeong Jo Jeon
BTBum Sik Tae
Bum Sik Tae
HCHoon Choi
Hoon Choi
JBJae Hyun Bae
Jae Hyun Bae
JKJong Wook Kim
Jong Wook Kim
JPJae Young Park
Jae Young Park
Jeon BJ, et al. Investig Clin Urol. 2020 Jan;61(1):51-58. https://doi.org/10.4111/icu.2020.61.1.51

1 January 2025 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
BJByeong Jo Jeon
Byeong Jo Jeon
BTBum Sik Tae
Bum Sik Tae
JPJae Young Park
Jae Young Park
JBJae Hyun Bae
Jae Hyun Bae
Jeon BJ, et al. Investig Clin Urol. 2025 Apr;66:e26. https://doi.org/10.4111/icu.20240433

1 January 2025 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
BJByeong Jo Jeon
Byeong Jo Jeon
YKYou Jin Ko
You Jin Ko
JPJae Young Park
Jae Young Park
JBJae Hyun Bae
Jae Hyun Bae
BTBum Sik Tae
Bum Sik Tae
Jeon BJ, et al. J Korean Med Sci. 2025 Aug;40:e244. https://doi.org/10.3346/jkms.2025.40.e244

31 December 2024 in International Neurourology Journal
Verified
Journal Article
Open access
PDF file
BJByeong Jo Jeon
Byeong Jo Jeon
HCHyun Kyung Chang
Hyun Kyung Chang
BTBum Sik Tae
Bum Sik Tae
JPJae Young Park
Jae Young Park
DYDuck Ki Yoon
Duck Ki Yoon
JBJae Hyun Bae
Jae Hyun Bae
Purpose: We aimed to assess the clinical efficacy and safety of combining silodosin and solifenacin for overactive bladder (OAB) in females.Methods: A retrospective analysis of 586 females with OAB was conducted. Patients received either combination therapy (silodosin 8 mg + solifenacin 5 mg) or monotherapy (solifenacin 5 mg) for 12 weeks. Baseline and follow-up assessments included the overactive bladder symptom score (OABSS), International Prostate Symptom Score (IPSS), quality of life (QoL), maximum flow rate (Qmax), voided volume (VV), and postvoid residual urine volume (PVR).Results: Overall, 287 and 299 patients received combination therapy and monotherapy respectively. Both groups experienced significant improvements in OABSS and total IPSS after 12 weeks. The combination therapy group demonstrated a greater improvement in QoL compared to the monotherapy group (P=0.031). No significant differences were observed in Qmax or VV between the groups. However, the combination therapy group showed a significant reduction in PVR compared to the monotherapy group (P<0.001).Conclusions: Combining silodosin with solifenacin significantly improved OAB symptoms and QoL in females. This combination therapy was particularly effective in reducing postvoid residual volume compared to solifenacin alone. These findings suggest that adding an alpha-blocker to antimuscarinic therapy can enhance OAB management and patient satisfaction.